Press review
Media
Press articles and media passages dealing with cases of meningiomas linked to Androcur, Lutéran, Lotényl, of testimonies and actions in justices of the victims, of scientific publications.
December 21, 2024
News
Media
Help scandal on the progestogen Androcur: Emmanuelle recounts her fight "trying but essential"
November 24, 2024
News
Legal procedures
Media
Androcur: Amavea files a complaint against X for endangering others and aggravated deception
Press contact
Emmanuelle Huet-Mignaton
contact@amavea.org
06 07 58 67 96
The press kit is available for free download.
-
Press review following the announcement by the ANSM of Méningiomes sur-risk with Lotéran and Lotényl on June 17, 2020
Read morePress review following the announcement by the ANSM of Méningiomes sur-risk with Lotéran and…
: Press review following the announcement by the ANSM of Méningiomes sur-risk with Lotéran and Lotényl on June 17, 2020 -
Menopause drugs or endometriosis increase the risk of brain tumor
Read moreMedicines for menopause or endometriosis increase the risk of cerebral tumor these ...
: Menopause drugs or endometriosis increase the risk of brain tumor -
Health: used to treat menopause, menstrual disorders and endometriosis, lutenyl and luteran would cause a tumor “over-risk”
Read moreHealth: used to treat menopause, menstrual disorders and endometriosis, lutenyl and ...
: Health: Used to treat menopause, menstrual disorders and endometriosis, lutenyl and luteran would cause a tumor “over-risk” -
Risk of confirmed brain tumors for progestogy drugs- Ouest France
Read moreRisk of confirmed brain tumors for progestogenic drugs- Ouest France Luteran, Lotényl…
: Risk of confirmed brain tumors for progestinic drugs- Ouest France
